Less Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome Combined With Noninvasive Ventilation in Anhui Province, China: A Retrospective Cohort Study
Clinical Pediatrics · 2023
DOI: 10.1177/00099228231152859 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Pediatrics, 2023. Verfasst von Xue Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of Chin…. Hauptthemen laut MEDLINE: Pulmonary Surfactants, Noninvasive Ventilation, Respiratory Distress Syndrome, Newborn, Bronchopulmonary Dysplasia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Medical Science and Technology Development Project of Chinese Health Commission.
Abstract (Originalsprache)
The less invasive surfactant application (LISA) technology has been widely used to manage breathing in premature infants. Premature infants with respiratory distress syndrome (RDS) were retrospectively analyzed and divided into 2 groups according to the drug delivery methods used: LISA versus traditional pulmonary surfactant injection (INSURE). The decrease of transcutaneous saturation (T c SO2) and heart rate during surfactant delivery in the LISA group was higher than that in the INSURE group ( P < .05). Between the 2 groups, there was no significant difference in the change in partial pressure of oxygen/fraction of inspired oxygen value before and after drug delivery; second-use pulmonary surfactant; noninvasive ventilation (NIV) failure rate; incidence of some complications; duration of NIV use; hospitalization time; and mortality ( P > .05). However, the incidence of bronchopulmonary dysplasia (BPD) in the LISA group was lower than that in the INSURE group ( P < .05). The clinical efficacy of LISA combined with the NIV treatment in premature infants with RDS was clear, and this treatment could reduce the incidence of BPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
- Department of Pediatrics, Anqing Municipal Hospital, Anqing, China.
- Department of Pediatrics, Fuyang People's Hospital, Fuyang, China.
- Department of Pediatrics, Maanshan Maternal and Child Health Hospital, Maanshan, China.
- Department of Pediatrics, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
- Department of Pediatrics, Huaibei Maternal and Child Health Hospital, Huaibei, China.
Förderung
- Medical Science and Technology Development Project of Chinese Health Commission
Zitieren
APA
Zhang, X., Pan, J., Zhu, L., Ye, Y., Fan, Z., Chen, X., Wang, H., Wei, G., & Zhang, L. (2023). Less Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome Combined With Noninvasive Ventilation in Anhui Province, China: A Retrospective Cohort Study. Clinical Pediatrics. https://doi.org/10.1177/00099228231152859
Vancouver
Zhang X, Pan J, Zhu L, Ye Y, Fan Z, Chen X, et al. Less Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome Combined With Noninvasive Ventilation in Anhui Province, China: A Retrospective Cohort Study. Clinical Pediatrics. 2023. doi:10.1177/00099228231152859
BibTeX
@article{Zhang2023,
author = {Zhang, Xue and Pan, Jiahua and Zhu, Liangmei and Ye, Yulan and Fan, Zhigang and Chen, Xin and Wang, Hui and Wei, Guangyou and Zhang, Lan},
title = {Less Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome Combined With Noninvasive Ventilation in Anhui Province, China: A Retrospective Cohort Study},
journal = {Clinical Pediatrics},
year = {2023},
doi = {10.1177/00099228231152859}
}
EUVIMED